The role of the agonist binding site in Ca2+ inhibition of the recombinant 5-HT3A receptor

Niemeyer, MI; Lummis, SCR

Abstract

The mechanism and site of action of Ca2+ at the recombinant murine 5-hydroxytryptamine (5-HT)3A receptor were investigated using whole-cell voltage clamp, radioligand binding and single-cell Ca2+ imaging. Inhibition of the 5-HT (3 ?M)-induced response by 10 mM Ca2+ reached a plateau at 68.5% inhibition, with half-maximal effect at 2.6 mM. This was due to an increase in EC50 from 2.35 to 3.87 ?M and a 30% reduction in Imax. Ca2+ also resulted in the inhibition of binding of both 5-HT3 receptor agonist [3H]m-chlorophenylbiguanide and antagonist [3H]granisetron due to an increase in Kd, with no change in Bmax. An increase in EC50 from 2.6 (1 mM Ca2+) to 4.7 ?M (10 mM Ca2+), with no change in maximal [Ca2+]i, was observed from Ca2+ imaging studies. Largely similar effects were observed with Mg2+. The combined data suggest that Ca2+ acting at a site that directly or indirectly influences the agonist binding site plays a significant role in its inhibitory effect at the 5-HT3 receptor. © 2001 Published by Elsevier Science B.V.

Más información

Título según WOS: The role of the agonist binding site in Ca2+ inhibition of the recombinant 5-HT3A receptor
Título según SCOPUS: The role of the agonist binding site in Ca2+ inhibition of the recombinant 5-HT3A receptor
Título de la Revista: EUROPEAN JOURNAL OF PHARMACOLOGY
Volumen: 428
Número: 2
Editorial: Elsevier
Fecha de publicación: 2001
Página de inicio: 153
Página final: 161
Idioma: English
URL: http://linkinghub.elsevier.com/retrieve/pii/S0014299901012511
DOI:

10.1016/S0014-2999(01)01251-1

Notas: ISI, SCOPUS